Literature DB >> 3115799

3-Aminobenzamide, an inhibitor of poly(ADP-ribose) polymerase, is a stimulator, not an inhibitor, of DNA repair.

J E Cleaver1, W F Morgan.   

Abstract

An inhibitor of poly(ADP-ribose) synthesis, 3-aminobenzamide (3AB), at low concentrations (0.01-0.1 mM) was found to reduce strand-break frequencies and increase repair replication in human lymphoid cells damaged by methyl methanesulfonate. A concentration of 0.1 mM 3AB was adequate to produce a maximum effect on strand-break frequencies and repair replication. This evidence, together with our previous measurements, demonstrates that 3AB cannot be regarded as an inhibitor of DNA repair; rather, it actually accelerates the ligation of DNA repair patches. Previous considerations of 3AB as a repair inhibitor may have derived from the use of excessive concentrations above 1 mM that may have stimulated additional damage and from the use of ethyl alcohol as a solvent for 3AB. Interpretations of the role of single-strand breaks and poly(ADP-ribose) in DNA repair, differentiation, and gene activity may need reevaluation because they have frequently been based on an erroneous notion of 3AB as a repair inhibitor, when its mode of action is, in fact, more complex.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115799     DOI: 10.1016/0014-4827(87)90385-5

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  3 in total

Review 1.  Inhibitors and activators of ADP-ribosylation reactions.

Authors:  M Banasik; K Ueda
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

2.  Differential response of human and rodent cell lines to chemical inhibition of the repair of potentially lethal damage.

Authors:  J B Little; A M Ueno; W K Dahlberg
Journal:  Radiat Environ Biophys       Date:  1989       Impact factor: 1.925

3.  Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself.

Authors:  Cian M McCrudden; Martin G O'Rourke; Kim E Cherry; Hiu-Fung Yuen; Declan O'Rourke; Muhammad Babur; Brian A Telfer; Huw D Thomas; Patrick Keane; Thiagarajan Nambirajan; Chris Hagan; Joe M O'Sullivan; Chris Shaw; Kaye J Williams; Nicola J Curtin; David G Hirst; Tracy Robson
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.